Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ralf Kohnen

Showing results (11-20 of 69) with videos related to

Pageof 7
Sort By:
Urologia Internationalis|December 8, 2010
A special terpene combination (Rowatinex®) improves stone clearance after extracorporeal shockwave lithotripsy in urolithiasis patients: results of a placebo-controlled randomised controlled trialImre Romics, György Siller, Ralf Kohnen, et al.
The Cochrane Database of Systematic Reviews|March 18, 2011
Dopamine agonists for restless legs syndromeHanna Scholz, Claudia Trenkwalder, Ralf Kohnen, et al.
Sleep Medicine Reviews|June 11, 2013
What treatment works best for restless legs syndrome? Meta-analyses of dopaminergic and non-dopaminergic medicationsMagdolna Hornyak, Hanna Scholz, Ralf Kohnen, et al.
Health and Quality of Life Outcomes|September 22, 2011
Psychological distress of patients suffering from restless legs syndrome: a cross-sectional studyHanna Scholz, Heike Benes, Svenja Happe, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 15, 2007
Definition of restless legs syndrome, how to diagnose it, and how to differentiate it from RLS mimicsHeike Benes, Arthur S Walters, Richard P Allen, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 18, 2006
Validation of the "L-DOPA test" for diagnosis of restless legs syndromeKarin Stiasny-Kolster, Ralf Kohnen, Jens Carsten Möller, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 25, 2004
Patch application of the dopamine agonist rotigotine to patients with moderate to advanced stages of restless legs syndrome: a double-blind, placebo-controlled pilot studyKarin Stiasny-Kolster, Ralf Kohnen, Erwin Schollmayer, et al.
Archives of General Psychiatry|May 14, 2003
Placebo or active control trials of antipsychotic drugs?W Wolfgang Fleischhacker, Pal Czobor, Martina Hummer, et al.
Sleep|July 2, 2013
Validation of the Multiple Suggested Immobilization Test: A Test for the Assessment of Severity of Restless Legs Syndrome (Willis-Ekbom Disease)Diego Garcia-Borreguero, Ralf Kohnen, Lindsay Boothby, et al.
The Journal of Clinical Psychiatry|April 29, 2003
Early improvement under mirtazapine and paroxetine predicts later stable response and remission with high sensitivity in patients with major depressionArmin Szegedi, Matthias J Müller, Ion Anghelescu, et al.
Pageof 7

Showing results (11-20 of 69) with videos related to

Sort By:
Pageof 7
Urologia Internationalis|December 8, 2010
A special terpene combination (Rowatinex®) improves stone clearance after extracorporeal shockwave lithotripsy in urolithiasis patients: results of a placebo-controlled randomised controlled trialImre Romics, György Siller, Ralf Kohnen, et al.
The Cochrane Database of Systematic Reviews|March 18, 2011
Dopamine agonists for restless legs syndromeHanna Scholz, Claudia Trenkwalder, Ralf Kohnen, et al.
Sleep Medicine Reviews|June 11, 2013
What treatment works best for restless legs syndrome? Meta-analyses of dopaminergic and non-dopaminergic medicationsMagdolna Hornyak, Hanna Scholz, Ralf Kohnen, et al.
Health and Quality of Life Outcomes|September 22, 2011
Psychological distress of patients suffering from restless legs syndrome: a cross-sectional studyHanna Scholz, Heike Benes, Svenja Happe, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 15, 2007
Definition of restless legs syndrome, how to diagnose it, and how to differentiate it from RLS mimicsHeike Benes, Arthur S Walters, Richard P Allen, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 18, 2006
Validation of the "L-DOPA test" for diagnosis of restless legs syndromeKarin Stiasny-Kolster, Ralf Kohnen, Jens Carsten Möller, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 25, 2004
Patch application of the dopamine agonist rotigotine to patients with moderate to advanced stages of restless legs syndrome: a double-blind, placebo-controlled pilot studyKarin Stiasny-Kolster, Ralf Kohnen, Erwin Schollmayer, et al.
Archives of General Psychiatry|May 14, 2003
Placebo or active control trials of antipsychotic drugs?W Wolfgang Fleischhacker, Pal Czobor, Martina Hummer, et al.
Sleep|July 2, 2013
Validation of the Multiple Suggested Immobilization Test: A Test for the Assessment of Severity of Restless Legs Syndrome (Willis-Ekbom Disease)Diego Garcia-Borreguero, Ralf Kohnen, Lindsay Boothby, et al.
The Journal of Clinical Psychiatry|April 29, 2003
Early improvement under mirtazapine and paroxetine predicts later stable response and remission with high sensitivity in patients with major depressionArmin Szegedi, Matthias J Müller, Ion Anghelescu, et al.
Pageof 7